The FY22 Laboratory Directed Research and Development (LDRD) process has now been initiated (see email from Director Witherell dated 12/14/2020). There will be Area-wide, Early Career, and Lab-wide Initiative tracks. Please see a description of these tracks in the call for proposals and the FY22 Bioscience Area priorities.
Please take note of the processing and close deadlines as you plan for year-end activities related to proposals, subcontracts, bridge funding requests, travel expense reimbursements, and effort (LETS).
Molecular Biophysics and Integrated Bioimaging (MBIB) Division Director Paul Adams has announced a number of changes in the Division leadership, effective July 21.
As shared by Nikki Humphreys with Biosciences staff on May 26, the 2020 Berkeley Lab Performance Review process has officially kicked off. Read the announcement here.
Mary Maxon, Associate Laboratory Director for Biosciences, announces that a Strategic Programs Development Group (SPDG) has been established in the Biosciences Area at Lawrence Berkeley National Laboratory (Berkeley Lab). The group will be led by Katy Christiansen, who has been with the Area for six years in a strategic planning and program development capacity.